From the Editor

If the battle against Alzheimer’s disease and other forms of dementia were solely a question of pharmaceutical interventions, the picture would be quite depressing: No new Alzheimer’s therapies have won federal approval since 2003, and recent Alzheimer’s clinical trials have had a 99 percent failure rate. Fortunately, however, there is a second front in this […]


Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.